🔎 Trials Near Me

Home › Cholesterol › North Carolina

Cholesterol clinical trials in North Carolina

7 studies for Cholesterol are looking for participants at sites in North Carolina.

Cities in North Carolina

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

  • Asheville Cardiology Associates Research Department, Asheville
  • Novant Health Clinical Research/Heart & Vascular Institute, Charlotte
  • Mecklenburg Heart Specialists, Charlotte
  • and 6 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

  • Duke Early Phase Clinical Research, Durham
  • Peters Medical Research, High Point
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Sep 18, 2026 · NCT07491172

A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.

  • Research Site, Durham
  • Research Site, Morehead City
  • Research Site, Statesville
  • and 2 more
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 10, 2026 · NCT07619131

A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia

  • Monroe Biomedical Research, Monroe
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 30, 2026 · NCT07610278

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

  • Velocity Clinical Research - Durham, Durham
  • Accellacare of Wilmington, Wilmington
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Jul 22, 2026 · NCT07477704

Pharmacogenomic Informed Statin Prescribing

  • Durham VA Medical Center, Durham, NC, Durham
Recruiting
Ages 40 to 75 · All sexes · Updated Apr 13, 2026 · NCT06568601

Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial

  • Wake Forest University Health Sciences, Winston-Salem
RecruitingPhase 2
Ages 40 to 75 · All sexes · Updated Feb 27, 2026 · NCT06488105

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.